Celldex Therapeutics CLDX Business Segments — Facility Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept cldx:FacilityExpense.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's business segments — facility expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Celldex Therapeutics's business segments — facility expense?
- Celldex Therapeutics (CLDX) reported business segments — facility expense of $940K in Q1 2026.
- How has Celldex Therapeutics's business segments — facility expense changed year-over-year?
- Celldex Therapeutics's business segments — facility expense decreased by 33.1% year-over-year, from $1.41M to $940K.
- What does business segments — facility expense mean?
- This metric represents the overhead costs associated with maintaining the physical infrastructure, such as laboratories and office space, required to support the primary business segment. It includes rent, utilities, and maintenance expenses necessary for ongoing operations. Tracking this metric provides insight into the fixed cost structure and operational footprint of the company's research activities.